Vivani Medical
VANI
51 hedge funds and large institutions have $13.2M invested in Vivani Medical in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 7 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 15
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 50 → 51 (+1)
10% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $2.04M
45% less capital invested
Capital invested by funds: $24M → $13.2M (-$10.8M)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.49M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.41M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$914K |
| 4 |
Goldman Sachs
New York
|
+$749K |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$569K |
Top Sellers
VANI Hedge Fund Activity: Q3 2015 in Review
51 of the 3,581 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2015, worth a combined $13.2M — down 45% from $24M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VANI positions and 7 closed out — a net gain of 1 holder — while 21 added to existing stakes and 15 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.49M. The largest seller was TIAA CREF Investment Management, cutting an estimated $931K.
- 51 institutional investors held Vivani Medical (VANI) as of Q3 2015, up from 50 in Q2 2015.
- Funds reported $13.2M of Vivani Medical stock for Q3 2015, down 45% quarter-over-quarter.
- 8 funds opened new Vivani Medical positions in Q3 2015 and 7 closed out, a net change of +1 holder.
- The largest Vivani Medical buyer in Q3 2015 was Vanguard Group, an estimated $1.49M added.
- The largest Vivani Medical seller in Q3 2015 was TIAA CREF Investment Management, an estimated $931K sold.
Based on aggregated 13F filings for Q3 2015.